Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 9.77% is 15% below its 5-year average of 11.55%, near the low end of its 5-year range (8.63%–21.31%).
As of the fiscal period ended Tuesday, June 30, 2026. 4.22% below its 12-month average of 10.20%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation.
RETURN ON EQUITY (ROE)
9.77%
RETURN ON EQUITY (ROE) AVG TTM
10.20%
RETURN ON EQUITY (ROE) AVG 3Y
10.66%
RETURN ON EQUITY (ROE) AVG 5Y
11.55%
RETURN ON EQUITY (ROE) AVG 10Y
17.78%
RETURN ON EQUITY (ROE) AVG 15Y
16.32%
RETURN ON EQUITY (ROE) AVG 20Y
16.58%
CURRENT VS TTM AVG
-4.22%
CURRENT VS 3Y AVG
-8.32%
CURRENT VS 5Y AVG
-15.41%
CURRENT VS 10Y AVG
-45.04%
CURRENT VS 15Y AVG
-40.12%
CURRENT VS 20Y AVG
-41.05%
SECTOR MEDIAN · HEALTHCARE
13.25%
median of 83 covered companies
CURRENT VS SECTOR MEDIAN
-26.25%
vs the sector median at left
Align Technology, Inc.
Market Cap
$10.99B
Return on Equity (ROE)
9.77%
TTM Avg
10.20%
3Y Avg
10.66%
5Y Avg
11.55%
Market Cap
$11.26B
Return on Equity (ROE)
-57.18%
TTM Avg
-651.33%
3Y Avg
-315.37%
5Y Avg
-198.08%
Market Cap
$11.32B
Return on Equity (ROE)
8.63%
TTM Avg
6.23%
3Y Avg
8.78%
5Y Avg
10.01%
Market Cap
$11.56B
Return on Equity (ROE)
N/A
TTM Avg
329.18%
3Y Avg
200.63%
5Y Avg
164.66%
Market Cap
$10.41B
Return on Equity (ROE)
20.31%
TTM Avg
18.80%
3Y Avg
15.17%
5Y Avg
15.31%
Market Cap
$10.25B
Return on Equity (ROE)
-0.17%
TTM Avg
18.91%
3Y Avg
22.60%
5Y Avg
24.60%
Market Cap
$10.23B
Return on Equity (ROE)
3.10%
TTM Avg
-8.94%
3Y Avg
-15.72%
5Y Avg
1.14%
Market Cap
$10.12B
Return on Equity (ROE)
12.77%
TTM Avg
11.88%
3Y Avg
12.69%
5Y Avg
13.50%
Market Cap
$10.12B
Return on Equity (ROE)
11.23%
TTM Avg
7.12%
3Y Avg
6.90%
5Y Avg
7.16%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Align Technology, Inc. (ALGN) | $10.99B | 9.77% | 10.20% | 10.66% | 11.55% |
| Tempus AI, Inc. (TEM)vs › | $11.26B | -57.18% | -651.33% | -315.37% | -198.08% |
| Bio-Techne Corporation (TECH)vs › | $11.32B | 8.63% | 6.23% | 8.78% | 10.01% |
| DaVita Inc. (DVA)vs › | $11.56B | N/A | 329.18% | 200.63% | 164.66% |
| Universal Health Services, Inc. (UHS)vs › | $10.41B | 20.31% | 18.80% | 15.17% | 15.31% |
| Molina Healthcare, Inc. (MOH)vs › | $10.25B | -0.17% | 18.91% | 22.60% | 24.60% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.23B | 3.10% | -8.94% | -15.72% | 1.14% |
| Henry Schein, Inc. (HSIC)vs › | $10.12B | 12.77% | 11.88% | 12.69% | 13.50% |
| Globus Medical, Inc. (GMED)vs › | $10.12B | 11.23% | 7.12% | 6.90% | 7.16% |
| Encompass Health Corporation (EHC)vs › | $11.95B | 23.91% | 22.63% | 21.83% | 21.13% |
ROE
9.8%
ROA
6.4%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 9.77% |
| 2026-03-31 | 10.36% |
| 2025-12-31 | 10.13% |
| 2025-09-30 | 9.56% |
| 2025-06-30 | 11.18% |
| 2025-03-31 | 10.79% |
| 2024-12-31 | 10.94% |
| 2024-09-30 | 11.19% |
| 2024-06-30 | 11.90% |
| 2024-03-31 | 12.30% |
| 2023-12-31 | 12.26% |
| 2023-09-30 | 9.54% |
| 2023-06-30 | 8.63% |
| 2023-03-31 | 9.05% |
| 2022-12-31 | 10.04% |
| 2022-09-30 | 13.82% |
| 2022-06-30 | 17.20% |
| 2022-03-31 | 19.25% |
| 2021-12-31 | 21.31% |
| 2021-09-30 | 21.04% |
| 2021-06-30 | 20.64% |
| 2021-03-31 | 13.50% |
| 2020-12-31 | 54.92% |
| 2020-09-30 | 57.30% |
| 2020-06-30 | 59.80% |
| 2020-03-31 | 66.21% |
| 2019-12-31 | 32.89% |
| 2019-09-30 | 32.09% |
| 2019-06-30 | 30.37% |
| 2019-03-31 | 29.96% |
| 2018-12-31 | 31.94% |
| 2018-09-30 | 26.25% |
| 2018-06-30 | 24.18% |
| 2018-03-31 | 22.87% |
| 2017-12-31 | 20.12% |
| 2017-09-30 | 22.74% |
| 2017-06-30 | 22.03% |
| 2017-03-31 | 20.92% |
| 2016-12-31 | 19.06% |
| 2016-09-30 | 19.64% |
| 2016-06-30 | 18.38% |
| 2016-03-31 | 16.63% |
| 2015-12-31 | 16.98% |
| 2015-09-30 | 16.87% |
| 2015-06-30 | 18.88% |
| 2015-03-31 | 18.85% |
| 2014-12-31 | 19.37% |
| 2014-09-30 | 20.58% |
| 2014-06-30 | 21.46% |
| 2014-03-31 | 19.91% |
| 2013-12-31 | 10.14% |
| 2013-09-30 | 5.46% |
| 2013-06-30 | -0.66% |
| 2013-03-31 | -0.76% |
| 2012-12-31 | 10.10% |
| 2012-09-30 | 11.10% |
| 2012-06-30 | 15.21% |
| 2012-03-31 | 13.74% |
| 2011-12-31 | 13.59% |
| 2011-09-30 | 12.29% |
| 2011-06-30 | 12.50% |
| 2011-03-31 | 18.69% |
| 2010-12-31 | 19.66% |
| 2010-09-30 | 21.10% |
| 2010-06-30 | 2.72% |
| 2010-03-31 | -6.40% |
| 2009-12-31 | -11.45% |
| 2009-09-30 | 8.82% |
| 2009-06-30 | 32.73% |
| 2009-03-31 | 33.96% |
| 2008-12-31 | 36.60% |
| 2008-09-30 | 12.63% |
| 2008-06-30 | 15.36% |
| 2008-03-31 | 19.24% |
| 2007-12-31 | 22.17% |
| 2007-09-30 | 8.48% |
| 2007-06-30 | -5.45% |
| 2007-03-31 | -23.46% |
| 2006-12-31 | -41.84% |
| 2006-09-30 | -18.98% |
| 2006-06-30 | -8.65% |
| 2006-03-31 | -5.42% |
| 2005-12-31 | 1.51% |
| 2005-09-30 | 2.17% |
| 2005-06-30 | 7.45% |
| 2005-03-31 | 11.11% |
| 2004-12-31 | 10.23% |
| 2004-09-30 | 9.71% |
| 2004-06-30 | 3.46% |
| 2004-03-31 | -12.93% |
| 2003-12-31 | -31.95% |
| 2003-09-30 | -59.37% |
| 2003-06-30 | -89.93% |
